1. Home
  2. OCS vs ECVT Comparison

OCS vs ECVT Comparison

Compare OCS & ECVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • ECVT
  • Stock Information
  • Founded
  • OCS 2003
  • ECVT 1935
  • Country
  • OCS Switzerland
  • ECVT United States
  • Employees
  • OCS N/A
  • ECVT N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • ECVT Major Chemicals
  • Sector
  • OCS Health Care
  • ECVT Industrials
  • Exchange
  • OCS Nasdaq
  • ECVT Nasdaq
  • Market Cap
  • OCS 956.4M
  • ECVT 1.0B
  • IPO Year
  • OCS N/A
  • ECVT 2017
  • Fundamental
  • Price
  • OCS $17.34
  • ECVT $9.37
  • Analyst Decision
  • OCS Strong Buy
  • ECVT Strong Buy
  • Analyst Count
  • OCS 4
  • ECVT 3
  • Target Price
  • OCS $35.75
  • ECVT $11.67
  • AVG Volume (30 Days)
  • OCS 14.2K
  • ECVT 1.4M
  • Earning Date
  • OCS 11-06-2025
  • ECVT 10-30-2025
  • Dividend Yield
  • OCS N/A
  • ECVT N/A
  • EPS Growth
  • OCS N/A
  • ECVT N/A
  • EPS
  • OCS N/A
  • ECVT N/A
  • Revenue
  • OCS $960,668.00
  • ECVT $723,462,000.00
  • Revenue This Year
  • OCS $11.49
  • ECVT $16.62
  • Revenue Next Year
  • OCS $1,784.02
  • ECVT $6.11
  • P/E Ratio
  • OCS N/A
  • ECVT N/A
  • Revenue Growth
  • OCS N/A
  • ECVT 4.93
  • 52 Week Low
  • OCS $11.78
  • ECVT $5.24
  • 52 Week High
  • OCS $23.08
  • ECVT $9.69
  • Technical
  • Relative Strength Index (RSI)
  • OCS 48.91
  • ECVT 62.56
  • Support Level
  • OCS $16.94
  • ECVT $9.04
  • Resistance Level
  • OCS $17.34
  • ECVT $9.69
  • Average True Range (ATR)
  • OCS 0.40
  • ECVT 0.26
  • MACD
  • OCS 0.08
  • ECVT 0.02
  • Stochastic Oscillator
  • OCS 73.35
  • ECVT 63.48

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About ECVT Ecovyst Inc.

Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has two reporting segments: Ecoservices and Advanced Materials & Catalysts. Ecoservices provides sulfuric acid recycling to the North American refining industry for the production of alkylate and provides on-purpose virgin sulfuric acid for water treatment, mining, and industrial applications. Maximum revenue is generated from Ecoservices segment.

Share on Social Networks: